Our Team
Bringing the Science to Life! Our team brings together leaders with exceptional expertise in healthcare innovation, regulatory navigation, and AI-driven medical advancements. From pioneering precision medicine and molecular diagnostics to driving biotech companies through IPOs and acquisitions, our collective experience shapes the future of personalized healthcare. With a shared commitment to innovation and patient-centered solutions, we are transforming the intersection of technology and medicine.
Leadership:
Travis Wold
Chief Executive Officer
CCO at Circulogene: Led the company from startup phase to a $300M acquisition. International Director at Veracyte: Spearheaded global expansion and strategic growth. Exit after a successful IPO. CEO of Kusko: Drove the company from startup to a $50M acquisition. 20 Years of Biotech Leadership: Extensive experience building biotech companies, guiding them to IPOs or successful exits.
Mikhail Teverovskiy
Chief Technology Officer
AI & Medical Imaging Expert: Dr. Mikhail Teverovskiy specializes in AI for cancer diagnostics and medical imaging. IEEE Senior Member: Recognized leader with extensive publications advancing AI in healthcare. Precision Medicine Pioneer: Applies AI to pathology, enhancing diagnostic accuracy and patient outcomes.
Lizabeth Katsnelson, PhD
AI Data Scientist
Computational Biologist in Cancer Diagnostics: Focused on integrating multi- omics and clinical data for enhanced patient stratification and personalized care. Expertise in Cancer Biology & Precision Medicine: Skilled in machine learning and bioinformatics to drive advancements in precision medicine. Data-Driven Therapeutic Innovator: Dedicated to using computational strategies to improve cancer diagnostics and patient outcomes.
Founders:
Aris Tsirigos, PhD
Co-Founder
Co-Founder, Inventor and Patent Holder in AI-Driven Healthcare: Owner of multiple patents, credited with significant discoveries that advance the application of AI in medical diagnostics. Internationally Renowned Pioneer in Genetic Forecasting: Recognized leader in histology-based genetic forecasting, revolutionizing predictive medicine and personalized patient care. Scientific Leadership & Visionary: Highly respected for driving innovations at the intersection of AI and pathology, with a commitment to transforming healthcare through cutting-edge technology and research.
Matija Snuderl, MD
Co-Founder
Co-Founder & Regulatory Affairs Specialist: Extensive expertise in navigating FDA, CLIA, NY State DOH, and AMA regulations and reimbursement processes. Professor of Pathology & Director of Molecular Pathology at NYU Langone: A leading figure in pathology with a focus on advancing molecular diagnostics. Global Authority in Precision Medicine and Molecular AI: Recognized internationally for pioneering work in precision medicine and the integration of AI in molecular diagnostics.
Daniel Orringer, MD
Co-Founder
Co-Founder: Key architect and visionary behind innovative healthcare solutions. Associate Professor of Neurosurgery at NYU Langone: Esteemed faculty member with a commitment to advancing neurosurgical practice. Top NYC Brain Surgeon and AI Thought Leader: Renowned for expertise in neurosurgery and pioneering the use of AI in clinical medicine. Expert in Clinical Implementation: Focused on integrating AI into medical practice to improve patient outcomes and healthcare efficiency.